Publication: Itraconazole for Treatment of Oral Candidosis in Pediatric Cancer Patients
Issued Date
1997-06-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-0030868809
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.80, No.6 (1997), 357-362
Suggested Citation
Prapun Aanpreung, Gavivan Veerakul Itraconazole for Treatment of Oral Candidosis in Pediatric Cancer Patients. Journal of the Medical Association of Thailand. Vol.80, No.6 (1997), 357-362. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/18123
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Itraconazole for Treatment of Oral Candidosis in Pediatric Cancer Patients
Author(s)
Other Contributor(s)
Abstract
Oral candidosis commonly occurs in malignancy children undergoing antineoplastic chemotherapy. Inadequate response to antifungal treatment leads to a risk of disseminated infection. The aim of this study is to evaluate the efficacy and side effects of itraconazole on treatment of oral candidosis. Fourteen children with malignancy undergoing chemotherapy received itraconazole 100 - 200 mg/day for 10 days to treat oral candidosis. The severity of disease was defined as mild and moderate depending on the number of lesions and symptoms. Oropharyngeal lesions and symptoms were recorded initially and daily. Blood chemistries were done on day 0, day 10 and day 16. The overall response rate was 87.5 per cent. The mild group (4 cases) had a response rate of 100 per cent which had lesions and symptoms resolved on day 2 and day 1.5 ± 0.7 respectively. The moderate group (10 cases) had 8 responders (80%) whose lesions and symptoms resolved on day 6 ± 2.5 and day 4.1 ± 2.3 respectively. Side effects and abnormal blood chemistry values were not seen.